Cigna Q4 Earnings Top On Higher Enrollment, 2018 View Issued

Published 01/31/2018, 09:29 PM
Updated 10/23/2024, 11:45 AM

Cigna Corp. (NYSE:CI) came up with adjusted earnings per share of $1.94 for the fourth quarter, beating the Zacks Consensus Estimate of $1.87. Earnings also grew 3.7% year over year.

Better-than-expected earnings were primarily driven by strong contribution from its Global Supplemental Benefits segment.

Other Details

Cigna posted revenues of $10.53 billion, which surpassed the Zacks Consensus Estimate of $10.29 billion. Revenues grew 5.9% year over year.

Premiums were up 7% year over year to $8.2 billion, while fees increased 5% to $1.19 billion.

Total benefits and expenses of $9.78 billion increased 5% year over year, led by higher global health care medical cost.

The company’s medical enrollment grew to 15.91 million from 15.19 million in the year-ago quarter, driven by growth in its Commercial Mrket segment.

Cigna Corporation Price, Consensus and EPS Surprise

Strong Segment Performance

Global Health Care: Operating revenues of $8.3 billion were up 6% year over year on a 6.8% year-over-year increase in premiums and fees to $7.3 billion. The improvement was driven by customer growth in the Commercial Market segment. However, the upside was partially offset by reductions in Government customers.

Adjusted operating earnings were $397 million, down 2% year over year due to higher medical costs.

Global Supplemental Benefits: Operating revenues of $1.02 billion were up 17% year over year on a 17.2% increase in premiums and fees, reflecting continued business growth.

Adjusted operating income increased 28.5% year over year to $81 million, reflecting business growth and favorable claims experience, particularly in South Korea.

Global Disability and Life: Operating revenues of $1.1 billion were down 1% year over year due to a 1.4% decrease in premiums and fees.

Adjusted operating income declined 11.6% year over year to $61 million.

Financial Position

Cigna’s cash and marketable investments were of $1.2 billion as of Dec 31, 2017, down from $2.8 billion as of Dec 31, 2016.

Long-term debt was $5.2 billion as of Dec 31, 2017, reflecting a 9.3% increase year over year.

2018 Guidance

The company expects to earn in the range of $12.40 and $12.90, on a per share basis. Total revenue growth is projected in the range of 7% to 8% and medical customers are projected to grow by 0.3 million to 0.5 million lives.

The consolidated adjusted tax rate should fall in the range of 22.5% to 23.5%.

Zacks Rank and Other Releases

Cigna carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Other health insurers UnitedHealth Group Inc. (NYSE:UNH) , Anthem Inc. (NYSE:ANTM) and Aetna Inc. (NYSE:AET) beat estimates in the fourth quarter by 3.6%, 3.2% and 5.93%, respectively.

Wall Street’s Next Amazon (NASDAQ:AMZN)

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>



Cigna Corporation (CI): Free Stock Analysis Report

Aetna Inc. (AET): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.